Extracorporeal membrane oxygenation in fulminant myocarditis complicating systemic lupus erythematosus

Medical Journal of Australia

Volumn 176, Issue 8, 2002, Pages 374-375

  Leung, Michael C H ^a   Harper, Richard W ^a   Boxall, John ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INOTROPIC AGENT; STEROID;

ADULT; AORTA BALLOON; ARTICLE; CARDIOGENIC SHOCK; CASE REPORT; DRUG MEGADOSE; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL OXYGENATION; FEMALE; HEART FAILURE; HUMAN; MYOCARDITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT FAILURE;

EID: 0037090751     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2002.tb04458.x     Document Type: Article

References (12)

1. Sub-clinical systemic lupus erythematosus presenting with acute myocarditis
2. Acute myocarditis as an initial manifestation of systemic lupus erythematosus: A case report
3. Acute myocarditis and left ventricular aneurysm as presentation of systemic lupus erythematosus
4. Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock
5. Long-term survival with use of percutaneous extracorporeal life support in patients presenting with acute myocardial infarction and cardiovascular collapse
6. Rescue for acute myocarditis with shock by extracorporeal membrane oxygenation
7. Usefulness of extracorporeal membrane oxygenation for treatment of fulminant myocarditis and circulatory collapse
8. A clinical trial of immunosuppressive therapy for myocarditis
9. Randomised, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: Two-year follow-up results
10. Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus
11. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis